Nike results top estimates; retailer expects $986 million tariff refund

Nike delivered a stronger-than-anticipated fiscal fourth-quarter earnings report, topping Wall Street expectations on the headline numbers. However, the corporate win comes with a major asterisk: the bottom line was highly flattered by a massive, non-recurring $986 million tariff refund that masked ongoing softness in global sales and demand.

While headline profits surged, investors remain cautious about the underlying pace of the sportswear giant’s ongoing business turnaround.

1. The Numbers: A Flat Blueprint Flattered by Policy

Nike’s overall fiscal fourth-quarter performance highlights an accounting-driven boost rather than a massive breakout in consumer demand:

• The Earnings Beat: Nike reported a quarterly net income of $1.07 billion (or $0.72 per share), comfortably beating analyst consensus estimates of $0.12 per share.
• The Flat Top-Line: Total revenue for the quarter actually dipped 1% on a reported basis to $10.97 billion, illustrating that the business is still finding its footing. Total fiscal year revenue closed flat at $46.4 billion.
• The Gross Margin Spike: Gross margins jumped an impressive 890 basis points to 49.2%. Nike explicitly noted that without the expected 900-basis-point boost from the tariff recovery, underlying gross margins would have been roughly flat year-over-year.

 [ NIKE FY26 Q4 REVENUE VS. PROFIT BALANCE ]
 
  QUARTERLY REVENUE:  ▼ Down 1% to $10.97 Billion (Lowest haul since Feb 2022)
  
  NET INCOME BOOM:    ▲ $1.07 Billion (Up from $211 Million last year)
                             │
                             └──► Flat top-line driven by a $986M one-time tariff windfalls

2. Where is the $986 Million Coming From?

The unexpected billion-dollar benefit stems from a regulatory shift. In February, the U.S. Supreme Court ruled that tariffs previously collected under the International Emergency Economic Powers Act (IEEPA) were unauthorized.

This opened the gates for massive corporate clawbacks across the retail sector, with the U.S. government potentially owing brokers and companies up to $175 billion in cumulative refunds:

• The Regional Split: Out of the $986 million booked by Nike in Q4, $965 million is mapped to its core North America pipeline, while $21 million covers its Converse subsidiary.
• The Cash Drag: While the full $986 million was booked straight to Q4 earnings because recovery is deemed “probable,” it isn’t all cash in hand yet. Roughly $300 million arrived by the end of the fiscal year, leaving $686 million still trickling in through federal distribution pipelines.

The Consumer Backlash: The massive refund has already triggered legal friction. Consumers filed a class-action lawsuit against Nike, alleging that the company is “double-dipping” by keeping refunds for tariffs whose costs were already passed on to everyday shoppers via higher retail price tags.

3. The Core Undercurrents & The China Problem

Pulling back the financial curtain reveals that CEO Elliott Hill’s sweeping structural turnaround—pivoting back to traditional wholesale channels and moving away from a purely digital, direct-to-consumer (DTC) focus—is wrestling with weak macro sentiment.

Operational Core Segment	Performance Metrics	The Structural Reality
Greater China	Revenue fell 12% to $1.30 billion.	Remains a severe drag. Nike has staffed a dedicated local product creation team to design regional products in-country.
Wholesale vs. DTC	Wholesale rose 1%; DTC declined 7%.	Proves rivals like Hoka and On successfully captured market share when Nike historically pulled back from wholesale shelves.
Product Categories	Sportswear down double digits globally.	Performance gear saw single-digit gains, but lifestyle and Jordan streetwear lines remain intensely challenged.

The Executive Horizon

Looking forward into the next two quarters, outgoing CFO Matthew Friend confirmed that Nike maintains a highly conservative outlook, forecasting low-to-mid-single-digit revenue declines driven by high global oil prices, shipping disruptions in the Middle East, and volatile tariff shifts.

The stage is set for a fresh financial approach; incoming CFO Dave Denton (formerly the finance head at Pfizer) is slated to officially take over the reins in August to guide capital allocation through the next phase of the restructuring.